VEGFC and gastric adenocarcinoma: In contrast, Al-Moundhri et al. [16] from Oman demonstrated that there were no significant differences in the serum VEGF-C levels between gastric adenocarcinoma patients and controls, whereas the serum levels of VEGF-D were significantly higher in control subjects than in gastric adenocarcinoma patients.